Quick Overview: An estimated 40000 patients die every year from idiopathic pulmonary fibrosis ( Dr. Steven Nathan discusses What We're Learning from the Dan Culver, CO of the Cleveland Clinic discusses the objectives, design, and data collection of the

Ipf Pro Registries To Advance - Detailed Overview & Context

An estimated 40000 patients die every year from idiopathic pulmonary fibrosis ( Dr. Steven Nathan discusses What We're Learning from the Dan Culver, CO of the Cleveland Clinic discusses the objectives, design, and data collection of the Andreas Günther, MD of Justus-Liebig-University discusses the history, data collected, and achievements of the European Ayodeji Adegunsoye, MD, MS answers questions about the PFF Daniel Auclair, PhD, Multiple Myeloma Research Foundation, Norwalk, CT, emphasizes the need to modernize medicine through ...

Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France discusses the impact of ... Jim Loyd, MD presents during the Basics of Genetics and What We Know About Stem Cell Therapy session at the PFF Summit ... Presentation by Imre Noth, MD, Associate Professor of Medicine at the University of Chicago for the 2009 Pulmonary Fibrosis ...

Photo Gallery

IPF-PRO: Registries to Advance Research
What We’re Learning from the IPF-PRO Registry
Characteristics Of Patients In the IPF-PRO Registry
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) | Dan Culver, DO
The European IPF Registry (eurIPFreg) - Andreas Günther, MD
The PFF Registry: Insights From A Research Expert
21st century medicine: patient registries
Have You Enrolled in the PFF Registry?
Rare Disease Registry: Benefits of Registry
The importance of patient registries
Genetics 101 in IPF I Jim Loyd, MD
IRIS Registry Dashboard Demonstration – How to Track Performance and Evaluate Patient Outcomes
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored